NCT05432726
Prediction of Chemotherapy Toxicity and Survival in Elderly Cancer Patients by CARG Score No drug interventions Not Available Not Available not_yet_recruiting NCT04587479
A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04467853
A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06404528
Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours No drug interventions treatment Not Available recruiting NCT04739293
Study of ON 123300 in Patients With Advanced Cancer treatment 1 recruiting NCT05768139
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05430373
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors No drug interventions treatment 1 recruiting NCT05887492
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06088472
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors No drug interventions treatment 0 completed NCT05861895
A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05354323
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT05698888
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors No drug interventions treatment 1 terminated NCT05228015
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04621435
Imaging of Solid Tumors Using FAP-2286 No drug interventions diagnostic 1 recruiting NCT05747339
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors No drug interventions treatment Not Available not_yet_recruiting NCT05472220
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma No drug interventions treatment 1 withdrawn NCT05018273
Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06504368
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors No drug interventions treatment 1 recruiting NCT01037790
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer No drug interventions treatment 2 completed NCT01332721
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated No drug interventions treatment 1 completed NCT05357898
Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 terminated NCT00041171
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery treatment 3 withdrawn NCT05752552
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours No drug interventions treatment 1 recruiting NCT06403436
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03445858
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults treatment 0 completed NCT04538625
Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy prevention 3 completed NCT03303365
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence No drug interventions treatment Not Available completed NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) No drug interventions treatment 2 active_not_recruiting NCT05147272
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01791595
A Phase I Trial of AZD3965 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT04084951
Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT06059547
Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer No drug interventions treatment 2 recruiting NCT03818347
Hydrogen Gas for Cancer Rehabilitation No drug interventions treatment Not Available completed NCT03061305
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors No drug interventions Not Available Not Available recruiting NCT03760952
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling No drug interventions Not Available Not Available completed NCT03253575
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 No drug interventions Not Available Not Available suspended NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer. No drug interventions treatment 2 recruiting NCT01269918
A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain No drug interventions treatment Not Available completed NCT05666635
Study of LTC004 in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 not_yet_recruiting NCT05400265
Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor No drug interventions treatment 1 completed NCT06277804
A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor No drug interventions treatment 1 not_yet_recruiting NCT04892043
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT05865990
HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease No drug interventions treatment 2 recruiting NCT06348290
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects No drug interventions treatment 1 not_yet_recruiting NCT06003621
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients No drug interventions treatment 2 recruiting NCT05586321
Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03410121
Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy No drug interventions other Not Available active_not_recruiting NCT03017521
K-BASKET, TAS-117, PI3K/AKT Gene Aberration No drug interventions treatment 2 completed NCT05481502
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors No drug interventions other Not Available recruiting NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors No drug interventions diagnostic 1 recruiting NCT03728179
RACIN in Patients With Advanced TIL-negative Solid Tumors No drug interventions treatment 1 completed NCT03326479
POA Retrospective Repository No drug interventions Not Available Not Available unknown_status NCT06108479
Study of DF6215 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04515043
EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754) No drug interventions other 1 completed NCT05388487
Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT05309187
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors treatment 1 completed NCT03990233
A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours treatment 1 active_not_recruiting NCT03160833
A Study of HMPL-453 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 unknown_status NCT03929653
Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing No drug interventions Not Available Not Available unknown_status NCT05689853
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05359445
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT06032845
Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Solid Tumors (CASTLE-11) treatment 2 recruiting NCT04761198
A Study of Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors. basic_science 1 / 2 completed NCT03175497
Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05662397
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody treatment 1 / 2 recruiting NCT05605197
U87 CART in Treatment of Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT03873883
First-in-Human Study of EOS100850 in Patients With Cancer treatment 1 active_not_recruiting NCT04977128
89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors diagnostic Not Available unknown_status NCT04143711
Study of DF1001 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06326411
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors No drug interventions treatment 1 recruiting NCT05078593
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma No drug interventions treatment 1 completed NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04169178
Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status No drug interventions treatment 1 unknown_status NCT06104488
A Study of Avutometinib for People With Solid Tumor Cancers treatment 1 recruiting NCT06265688
First In Human Study of CX-2051 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06439888
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer treatment 1 / 2 recruiting NCT05055609
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors No drug interventions treatment 1 recruiting NCT04020185
Safety and Efficacy Study of IMSA101 in Refractory Malignancies No drug interventions treatment 1 / 2 completed NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors treatment 1 not_yet_recruiting NCT03545815
Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors. No drug interventions treatment 1 unknown_status NCT05888532
64Cu-GRIP B in Patients With Advanced Malignancies diagnostic 1 / 2 recruiting NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT03441100
TCR-engineered T Cells in Solid Tumors: IMA202-101 No drug interventions treatment 1 completed NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors No drug interventions treatment 2 recruiting NCT05607199
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics treatment 1 recruiting NCT04243499
First-in-Human Study of ICT01 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT04175899
Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia No drug interventions supportive_care Not Available unknown_status NCT05518799
CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours other Not Available completed NCT04901806
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors No drug interventions treatment 1 terminated NCT04537936
Psychotherapy Intervention for Latinos With Adv Cancer No drug interventions supportive_care Not Available recruiting NCT05099536
3D011-08 Monotherapy in Subjects With Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT03543813
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL No drug interventions treatment 1 / 2 completed NCT06391918
Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04803318
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors treatment 2 recruiting NCT06398418
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03008018
Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours No drug interventions treatment 1 completed NCT05559541
Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06063317
A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) treatment 1 recruiting NCT05779917
Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers No drug interventions treatment 1 recruiting NCT03761017
MGD019 DART® Protein in Unresectable/Metastatic Cancer treatment 1 active_not_recruiting NCT06462716
A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04130516
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab treatment 1 / 2 recruiting NCT04739696
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients. No drug interventions treatment Not Available active_not_recruiting NCT04585035
Study to Evaluate D-1553 in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT05060263
A Study of of HOT1030 in Patients With Advanced Solid Tumors No drug interventions health_services_research 1 unknown_status NCT06232863
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer No drug interventions treatment 1 recruiting NCT05230186
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. No drug interventions Not Available Not Available recruiting NCT05631886
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors treatment 1 recruiting NCT05435339
A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy No drug interventions treatment 1 / 2 terminated NCT03594422
A Study of HQP1351 in Patients With GIST or Other Solid Tumors treatment 1 recruiting NCT05242822
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations treatment 1 active_not_recruiting NCT03302325
Circulating Tumor DNA as Liquid Biopsy in Patients With Stage IV Solid Tumors, a Feasibility Study at MUSC HCC No drug interventions Not Available Not Available completed NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT03905148
Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors treatment 1 recruiting NCT04729348
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases treatment 2 terminated NCT04196257
BP1001-A in Patients With Advanced or Recurrent Solid Tumors treatment 1 recruiting NCT06433726
A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05242926
Absorption and Excretion of Oral Docetaxel treatment 1 withdrawn NCT05036226
COAST Therapy in Advanced Solid Tumors and Prostate Cancer treatment 1 / 2 recruiting NCT05868226
PRE-I-SPY Phase I/Ib Oncology Platform Program treatment 1 recruiting NCT03747965
Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors No drug interventions treatment 1 unknown_status NCT05480865
SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation treatment 1 recruiting NCT03706274
PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors No drug interventions treatment 1 withdrawn NCT05307874
Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05990920
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy No drug interventions treatment 1 active_not_recruiting NCT03398720
Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced Tumors No drug interventions treatment 1 recruiting NCT04092673
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies treatment 1 / 2 recruiting NCT06265727
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05060276
Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 withdrawn NCT06380660
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06462794
First In Human Study of CX-801 in Advanced Solid Tumors treatment 1 recruiting NCT06196294
GPC3/Mesothelin-CAR-γδT Cells Against Cancers treatment 1 recruiting NCT05623891
Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors diagnostic 0 not_yet_recruiting NCT00571389
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. No drug interventions Not Available Not Available recruiting NCT05086692
A Beta-only IL-2 ImmunoTherapY Study No drug interventions treatment 1 / 2 recruiting NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT03382340
IMX-110 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT04814667
A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib No drug interventions Not Available Not Available active_not_recruiting NCT06240767
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils No drug interventions treatment 1 recruiting NCT03209401
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies No drug interventions treatment 1 terminated NCT05763004
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03656172
Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor No drug interventions Not Available Not Available completed NCT05620472
Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 No drug interventions diagnostic 1 enrolling_by_invitation NCT03094169
AVID100 in Advanced Epithelial Carcinomas No drug interventions treatment 1 / 2 terminated NCT04556669
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT05071846
MVX-ONCO-2 in Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT06027346
A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours No drug interventions treatment 1 recruiting NCT04842812
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05678010
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer No drug interventions treatment 1 recruiting NCT04983810
A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT04989010
Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors No drug interventions diagnostic Not Available unknown_status NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT06477614
Anti-cancer DC Cell Vaccination to Treat Solid Tumors No drug interventions treatment 1 recruiting NCT06218914
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation No drug interventions treatment 1 recruiting NCT03987555
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients No drug interventions Not Available Not Available recruiting NCT03004755
The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study No drug interventions Not Available Not Available recruiting NCT06056323
A Study of HB0045 Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03516123
A Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT04928508
Advanced or Recurrent Solid Tumors Treated With SHetA2 No drug interventions treatment 1 recruiting NCT06478108
Interventional Software for Multi-immunotherapy of Solid Tumors No drug interventions treatment 2 / 3 recruiting NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) No drug interventions treatment 1 active_not_recruiting NCT03045003
Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients No drug interventions supportive_care Not Available completed NCT03600090
Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer No drug interventions treatment 1 completed NCT02977364
A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours No drug interventions treatment 1 unknown_status NCT04946864
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer No drug interventions treatment 1 / 2 suspended NCT03161821
Circulating Tumor Cells in Solid Tumors No drug interventions Not Available Not Available completed NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05958121
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06383884
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion No drug interventions treatment 2 not_yet_recruiting NCT05276284
Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy No drug interventions treatment 1 / 2 recruiting NCT06195384
Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors No drug interventions treatment 1 recruiting NCT05947487
CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04310033
Impact of ICU on the Quality of Life in Cancer Patients No drug interventions Not Available Not Available completed NCT04219254
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04) No drug interventions treatment 1 / 2 recruiting NCT04671654
Systematic Evaluation of Human Explant Model Systems Engineering No drug interventions Not Available Not Available recruiting NCT04683354
Study of HL-085 in Patients With Advanced Solid Tumor Tumors No drug interventions treatment 1 completed NCT06026254
A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial No drug interventions treatment 1 active_not_recruiting NCT06098651
A Study of DCR-STAT3 in Adults With Solid Tumors No drug interventions treatment 1 recruiting NCT04650451
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors No drug interventions treatment 1 suspended NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04859777
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT05117177
New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer No drug interventions treatment 1 recruiting NCT06292845
Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents No drug interventions other Not Available recruiting NCT03728205
Yoga for Solid Tumor No drug interventions supportive_care Not Available withdrawn NCT04899505
Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology No drug interventions Not Available Not Available recruiting NCT03772561
Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 unknown_status NCT03274661
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors No drug interventions treatment 2 completed NCT06195293
Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors No drug interventions treatment 1 recruiting NCT06144671
GT201 Injection For The Treatment Of Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03147378
Food Effect Study of ModraDoc006 in Combination With Ritonavir No drug interventions treatment 1 completed NCT03915678
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT04443088
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies No drug interventions treatment 2 active_not_recruiting NCT04770207
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs No drug interventions treatment 2 recruiting NCT05381909
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors No drug interventions treatment 1 recruiting NCT04015609
Psychotherapy Intervention for Latinos With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT05084456
Oral Docetaxel in Patients With Normal or Impaired Liver Function No drug interventions treatment 1 withdrawn NCT04551885
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04913285
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors No drug interventions treatment 1 recruiting NCT05216432
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer No drug interventions treatment 1 recruiting NCT04306900
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers No drug interventions treatment 1 completed NCT03520075
Study of ASTX029 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05252975
Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS) No drug interventions treatment Not Available unknown_status NCT04474470
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT04121442
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors No drug interventions treatment 1 / 2 completed NCT04504942
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 2 unknown_status NCT05631899
CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03927599
Advanced Refractory Solid Tumors With TP53 Mutations Register Study No drug interventions Not Available Not Available unknown_status NCT04665206
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 or mNF2 Gene Mutations No drug interventions treatment 1 / 2 recruiting NCT06507306
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT04402606
Study on Skin Toxicities Induced by Cancer Treatments No drug interventions supportive_care Not Available completed NCT05759949
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent No drug interventions treatment 1 recruiting NCT03149549
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors No drug interventions treatment 1 / 2 terminated NCT06090513
Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients No drug interventions Not Available Not Available not_yet_recruiting NCT05131113
Stratification of Patients in Oncogeriatrics and Personalization of Interventions No drug interventions supportive_care Not Available completed NCT04976218
TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors No drug interventions treatment 1 recruiting NCT03892018
The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol No drug interventions treatment 1 terminated NCT03496519
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors No drug interventions treatment 1 withdrawn NCT05605119
First in Human, Dose Escalation, Dose Expansion Study of AUR105 No drug interventions treatment 1 recruiting NCT03523819
A Study of CS1002 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03081819
A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer No drug interventions other 1 completed NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT05601219
A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04597541
A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03324841
POA Prospective Repository No drug interventions Not Available Not Available unknown_status NCT04942717
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values No drug interventions Not Available Not Available recruiting NCT05759234
A Study of HS248 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03360734
Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors No drug interventions treatment 1 completed NCT03092934
A Study of AK-01 (LY3295668) in Solid Tumors No drug interventions treatment 1 / 2 completed NCT03686124
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT03951116
Study of FCN-437c in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05442996
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05069935
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04105335
A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT) No drug interventions treatment 1 active_not_recruiting NCT04927663
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression No drug interventions diagnostic 1 recruiting NCT06397963
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours No drug interventions treatment Not Available recruiting NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma No drug interventions treatment 1 completed NCT04428086
A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. No drug interventions treatment 1 completed NCT05597839
Study of DF9001 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06350539
Personalized Models for Cancer Research No drug interventions Not Available Not Available recruiting NCT05651022
DECOY20 Study in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05669430
A Study of GV20-0251 in Patients With Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT06473948
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects No drug interventions basic_science 1 not_yet_recruiting NCT05054348
First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03084757
SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) No drug interventions screening Not Available active_not_recruiting NCT06436157
A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention No drug interventions supportive_care Not Available not_yet_recruiting NCT04014257
A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies No drug interventions treatment 1 completed NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT03992326
Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors No drug interventions treatment 1 terminated NCT03355066
A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03977766
Feasibility of a Process of Digital Validation of Chemotherapies in a Day Treatment Unit No drug interventions other Not Available unknown_status NCT04725474
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) No drug interventions treatment 1 / 2 active_not_recruiting NCT06372574
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors No drug interventions treatment 1 withdrawn NCT05868174
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors No drug interventions treatment 1 recruiting NCT04643574
NeoTIL in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03673020
Phase 1a Study to Evaluate Immunogenicity of ASV® No drug interventions treatment 1 completed NCT05322720
HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy No drug interventions treatment 2 not_yet_recruiting NCT05736731
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT03494231
A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04053673
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT05538676
Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors No drug interventions Not Available Not Available recruiting NCT03941262
Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy No drug interventions treatment 1 completed NCT03465592
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma No drug interventions treatment 1 / 2 recruiting NCT05866692
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03617692
Cannabis Use in Cancer Patients No drug interventions Not Available Not Available completed NCT03919292
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca No drug interventions treatment 1 / 2 recruiting NCT03823144
Intravital Microscopy in Human Solid Tumors No drug interventions diagnostic Not Available completed NCT04328844
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers No drug interventions treatment 1 active_not_recruiting NCT03030001
PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies No drug interventions treatment 1 / 2 unknown_status NCT03922204
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies No drug interventions treatment 1 unknown_status NCT06088004
Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03638804
89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors No drug interventions diagnostic Not Available unknown_status NCT04221204
A Monotherapy in Subjects With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06524804
A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined With Radiotherapy in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04165772
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors No drug interventions treatment 2 recruiting NCT05074472
A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors No drug interventions treatment 1 / 2 completed NCT02717572
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR No drug interventions diagnostic 1 completed NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03914872
Expanded Access Neoantigen Vaccine in Solid Tumors No drug interventions Not Available Not Available no_longer_available NCT05296772
Phase 1 First-in-human Study of JS014 No drug interventions treatment 1 recruiting NCT05114668
Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours No drug interventions treatment 1 active_not_recruiting NCT06469268
Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period No drug interventions supportive_care Not Available recruiting NCT04971369
Safety Study of 89Zr-NY001 PET Imaging in Patients No drug interventions diagnostic Not Available unknown_status NCT04315246
177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) No drug interventions treatment 1 / 2 withdrawn NCT03573310
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS No drug interventions treatment 1 active_not_recruiting NCT05416710
Universal Germline Testing in the Community No drug interventions Not Available Not Available recruiting NCT05840510
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) No drug interventions treatment 1 active_not_recruiting NCT04041310
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04811781
Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study No drug interventions Not Available Not Available completed NCT05986981
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers No drug interventions treatment 2 not_yet_recruiting NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05947695
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT06554795
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT05284214
Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors No drug interventions treatment 2 withdrawn NCT03778814
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors No drug interventions treatment 1 recruiting NCT03976050
Phase I Study of HL-085 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05582850
DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours No drug interventions treatment 1 recruiting NCT05223608
Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy No drug interventions treatment Not Available recruiting NCT02409108
Perfusion-Induced Hyperthermia for Metastatic Carcinoma No drug interventions device_feasibility Not Available completed NCT06506643
Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms No drug interventions treatment 1 / 2 active_not_recruiting NCT05944276
A Study of HB0045 Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT00410553
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery treatment 1 completed NCT02116777
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies treatment 1 / 2 completed NCT01263145
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer treatment 1 completed NCT00608361
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery treatment 1 completed NCT00070252
Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer treatment 1 / 2 completed NCT01061749
Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies treatment 1 completed NCT02054741
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer No drug interventions supportive_care Not Available completed NCT00888134
Selumetinib in Cancers With BRAF Mutations treatment 2 completed NCT01131234
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01276496
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery treatment 1 completed NCT00499135
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors treatment 1 completed NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy treatment 1 active_not_recruiting NCT01654965
Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors treatment 1 completed NCT02822365
Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors No drug interventions Not Available Not Available completed NCT01218620
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00217373
Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) treatment 1 completed NCT02775292
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 No drug interventions treatment 1 completed NCT00813423
Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy No drug interventions treatment 1 completed NCT02107443
Improving Communication in Older Cancer Patients and Their Caregivers No drug interventions supportive_care Not Available completed NCT01326702
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors No drug interventions treatment 1 / 2 completed NCT01122888
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme No drug interventions treatment 1 terminated NCT01625156
Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery No drug interventions treatment 1 completed NCT01264432
Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT00535119
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer No drug interventions treatment 1 completed NCT00878163
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery No drug interventions treatment 1 active_not_recruiting NCT02627430
Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer No drug interventions treatment 1 withdrawn NCT01154426
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01548482
Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery No drug interventions treatment 1 completed NCT01281176
High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01375829
Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery No drug interventions treatment 1 active_not_recruiting NCT00334789
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery No drug interventions treatment 1 completed NCT01971489
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT01093092
Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery No drug interventions treatment 1 terminated NCT00045201
Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01039155
Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy No drug interventions treatment 1 completed NCT01281150
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed